Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by SuperMoneyon Jun 08, 2018 1:01pm
24 Views
Post# 28146709

RE:RE:Banko or Dilution???

RE:RE:Banko or Dilution???Hotoffthepress, whenever you bashing, I buying. Whenever you pumping, I definitely selling. I always take actions oppositely as what you said. Lol. Just be aware of "pumping and dumping". Warning: This is only my opinion. It is NOT any investment advice. Do your own DD.
Hotoffthepress wrote: I'll also add that most of the expense is R&D so they can't reduce head count to preserve cash.  Last I heard they had 1 full time employee (CEO), I think the CFO and CMO are contracted on a part time basis.  No other employees.  Or has that changed?  No assets to sell, patents carry almost zero value in this market.  How do they keep this afloat?  Anyone talk to the CEO lately?


<< Previous
Bullboard Posts
Next >>